Skip to Main Content

Author Details

Marco Gargaro
University of Perugia
2014
62
22
PMIDPaper TitleJournal TitlePublished Year
36346356CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma.Am J Hematol2023
38003426Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function.Int J Mol Sci2023
37603175Use of CRISPR/CAS9 Technologies to Study the Role of TLR in Dendritic Cell Subsets.Methods Mol Biol2023
37122718The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1.Front Immunol2023
37081894A tryptophan metabolite prevents depletion of circulating endothelial progenitor cells in systemic low-grade inflammation.Front Immunol2023
36587540Isolation of extracellular vesicles from bitch's amnion-derived cells culture and their CD59 expression: Preliminary results.Theriogenology2023
36768851Microbiota-Associated HAF-EVs Regulate Monocytes by Triggering or Inhibiting Inflammasome Activation.Int J Mol Sci2023
36733497The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma.Oncoimmunology2023
36896128The circadian control of tryptophan metabolism regulates the host response to pulmonary fungal infections.PNAS Nexus2023
36484163Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia.Br J Haematol2023
34847078Anakinra restores cellular proteostasis by coupling mitochondrial redox balance to autophagy.J Clin Invest2022
35704993Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication.Immunity2022
35491676Liver gene therapy with intein-mediated F8 trans-splicing corrects mouse haemophilia A.EMBO Mol Med2022
36523595Sperm-carried IGF2 downregulated the expression of mitogens produced by Sertoli cells: A paracrine mechanism for regulating spermatogenesis?Front Endocrinol (Lausanne)2022
35218567Amniotic fluid stem cell-derived extracellular vesicles are independent metabolic units capable of modulating inflammasome activation in THP-1 cells.FASEB J2022
35236743Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite.J Immunother Cancer2022
33451129The Landscape of AhR Regulators and Coregulators to Fine-Tune AhR Functions.Int J Mol Sci2021
33924971Tryptophan Metabolites at the Crossroad of Immune-Cell Interaction via the Aryl Hydrocarbon Receptor: Implications for Tumor Immunotherapy.Int J Mol Sci2021
33503414Aspergillus fumigatus tryptophan metabolic route differently affects host immunity.Cell Rep2021
33693650Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation.Hum Mol Genet2021
33804124The Circadian Protein PER1 Modulates the Cellular Response to Anticancer Treatments.Int J Mol Sci2021
33633289Lipotoxic stress alters the membrane lipid profile of extracellular vesicles released by Huh-7 hepatocarcinoma cells.Sci Rep2021
34388589Prevalence of vitamin D deficiency and its prognostic impact on patients hospitalized with COVID-19.Nutrition2021
342902433-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine.Nat Commun2021
34281239<i>Hops/Tmub1</i> Heterozygous Mouse Shows Haploinsufficiency Effect in Influencing p53-Mediated Apoptosis.Int J Mol Sci2021
32226425Pharmacologic Induction of Endotoxin Tolerance in Dendritic Cells by L-Kynurenine.Front Immunol2020
31727470Targeting Aryl hydrocarbon receptor for next-generation immunotherapies: Selective modulators (SAhRMs) versus rapidly metabolized ligands (RMAhRLs).Eur J Med Chem2020
32024760Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation.Proc Natl Acad Sci U S A2020
31867855HOPS/TMUB1 retains p53 in the cytoplasm and sustains p53-dependent mitochondrial apoptosis.EMBO Rep2020
33159421Class IA PI3Ks regulate subcellular and functional dynamics of IDO1.EMBO Rep2020
33126625Use of a Zwitterionic Surfactant to Improve the Biofunctional Properties of Wool Dyed with an Onion (<i>Allium cepa</i> L.) Skin Extract.Antioxidants (Basel)2020
32605792A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function.J Autoimmun2020
32817121Thymosin α1 protects from CTLA-4 intestinal immunopathology.Life Sci Alliance2020
32351505Tolerance to FVIII: Role of the Immune Metabolic Enzymes Indoleamine 2,3 Dyoxigenase-1 and Heme Oxygenase-1.Front Immunol2020
30754712Onion (<i>Allium cepa</i> L.) Skin: A Rich Resource of Biomolecules for the Sustainable Production of Colored Biofunctional Textiles.Molecules2019
31265195Toll-like receptors as novel therapeutic targets for herpes simplex virus infection.Rev Med Virol2019
31406377An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development.Nat Immunol2019
31481962Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells.Front Immunol2019
30793469IL-35Ig-expressing dendritic cells induce tolerance via Arginase 1.J Cell Mol Med2019
29266750Binding Mode and Structure-Activity Relationships of ITE as an Aryl Hydrocarbon Receptor (AhR) Agonist.ChemMedChem2018
29886240S1P promotes migration, differentiation and immune regulatory activity in amniotic-fluid-derived stem cells.Eur J Pharmacol2018
30391205Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1.Biochem Pharmacol2018
30409884WDFY4 is required for cross-presentation in response to viral and tumor antigens.Science2018
29471184Targeting metabotropic glutamate receptors for the treatment of neuroinflammation.Curr Opin Pharmacol2018
29574719IL-35, a hallmark of immune-regulation in cancer progression, chronic infections and inflammatory diseases.Int J Cancer2018
29572360Altered compensatory cytokine signaling underlies the discrepancy between <i>Flt3<sup>-/-</sup></i> and <i>Flt3l<sup>-/-</sup></i> mice.J Exp Med2018
27696702Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1.J Cell Mol Med2017
28356656CpG Type A Induction of an Early Protective Environment in Experimental Multiple Sclerosis.Mediators Inflamm2017
28348230Deficiency of transcription factor RelB perturbs myeloid and DC development by hematopoietic-extrinsic mechanisms.Proc Natl Acad Sci U S A2017
28525281Interaction of 7-Alkoxycoumarins with the Aryl Hydrocarbon Receptor.J Nat Prod2017
  • 1 - 50 of 62

Recommended Authors

Karolinska Institute, Center for Molecular Medicine
Career Start Year 2012
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University
Career Start Year 2011
Number of shared co-authors 0
Texas Children's Cancer Center
Career Start Year 2010
Number of shared co-authors 0
Henan University
Career Start Year 2010
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 2009
Number of shared co-authors 0
Center for Personal Dynamic Regulomes, Stanford University School of Medicine
Career Start Year 2009
Number of shared co-authors 2
Peking University
Career Start Year 2009
Number of shared co-authors 0
McGill University
Career Start Year 2008
Number of shared co-authors 0
University of Illinois College of Medicine Rockford
Career Start Year 2007
Number of shared co-authors 0
Berlin Institute of Health at Charite - Universitatsmedizin Berlin
Career Start Year 2006
Number of shared co-authors 0
Genentech Inc.
Career Start Year 2005
Number of shared co-authors 0
University Hospital Bonn
Career Start Year 2004
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2003
Number of shared co-authors 0
Shandong University
Career Start Year 2003
Number of shared co-authors 0
David Geffen School of Medicine, University of California Los Angeles
Career Start Year 2002
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Frazer Institute, The University of Queensland
Career Start Year 2001
Number of shared co-authors 0
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 1
University of California San Diego
Career Start Year 1999
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 1
Boehringer Ingelheim Pharma GmbH & Co. KG
Career Start Year 1998
Number of shared co-authors 2
Ajou University
Career Start Year 1995
Number of shared co-authors 0
Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham
Career Start Year 1993
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1990
Number of shared co-authors 0
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 2
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 2
University of Michigan Medical School
Career Start Year 1989
Number of shared co-authors 0
Helen Wills Neuroscience Institute, University of California berkeley
Career Start Year 1988
Number of shared co-authors 0
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year 1966
Number of shared co-authors 1

Collaborators

University of Perugia
Co-authored papers 44
University of Perugia
Co-authored papers 18
University of Perugia
Co-authored papers 17
University of Perugia
Co-authored papers 15
Department of Pharmaceutical Sciences, University of Perugia
Co-authored papers 11
Weill Cornell School of Medicine
Co-authored papers 3
Department of Pharmaceutical Sciences, University of Perugia
Co-authored papers 3
Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche "Togo Rosati"
Co-authored papers 2
Department of Pharmaceutical Sciences, University of Perugia
Co-authored papers 2
Department of Pharmaceutical and Organic Chemistry, University of Granada
Co-authored papers 2
Englander Institute for Precision Medicine
Co-authored papers 1
Washington University School of Medicine
Co-authored papers 1
Institute of Pharmaceutical Sciences, ETH Zurich
Co-authored papers 1
Weill Cornell Medical College
Co-authored papers 1
Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche "Togo Rosati"
Co-authored papers 1
Wihuri Research Institute
Co-authored papers 1
University of Colorado Anschutz Medical Campus
Co-authored papers 1
National Institute of Arthritis
Co-authored papers 1
Albert Einstein College of Medicine
Co-authored papers 1
Herbert Irving Comprehensive Cancer Center, Columbia University
Co-authored papers 1
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Center for Personal Dynamic Regulomes, Stanford University
Co-authored papers 1
Institute of Pharmaceutical Sciences, ETH Zurich
Co-authored papers 1
Weill Cornell Medical College
Co-authored papers 1
Institute of Pharmaceutical Sciences, ETH Zurich
Co-authored papers 1
Weill Cornell Medical College
Co-authored papers 1
New York Medical College
Co-authored papers 1
University of Helsinki
Co-authored papers 1
Co-authored papers 1
Montefiore Medical Center, Albert Einstein College of Medicine
Co-authored papers 1